As a continuation of our studies on the effects of immune sera on cellular metabolism (Sevag and Miller, 1948) , we have investigated the effect of homologous rabbit immune serum on the activity of hexokinase isolated from yeast. This report represents the results of this study.
EXPERIMENTAL METHODS
Hexokinase was isolated from Fleischmann's bakers' yeast according to the method of Kunitz and McDonald (1946) , and the dialyzed "0.72" fraction was used for immunization and for activity tests with various sera. Uniform enzyme activity was maintained by preserving the preparation in 1 per cent glucose solution in the frozen state. This preparation compared with the five-times-crystallized hexokinase (specific activity, 1,440) of Kunitz and McDonald is only 10 per cent pure.
Immunization. Method 1: Four large male rabbits were immunized in the following manner: Five subcutaneous injections, given at 3-and 4-day intervals, varied from 1 to 3.5 ml. The protein content per ml was about 3 mg, which corresponds to 0.3 mg of 5-fold crystalline hexokinase. Sera collected 10 days after the last injection completely inhibited hexokinase activity.' To maintain the antibody content of these rabbits at a satisfactory level, a second series of four injections was given 2' months later. The rabbits were exsanguinated, and the sera were pooled, inactivated (56 C for 30 minutes), and kept in the frozen state without a preservative. (Freund and Bonanto, 1944; Halbert, Smolens, and Mudd, 1945) . The emulsion was prepared by being stirred in an electric mixer in the cold for about 3 minutes. Two volumes of 6 ml each of the emulsion were injected at different sites at the same time. A month later the serum from this rabbit was tested. It showed precipitating and complement-fixing titers higher than the sera described above but had no hexokinase-inhibiting activity. Under these conditions, hexokinase was either inactivated, producing antibodies incapable of inhibiting the active enzyme, or the amount injected was insufficient to produce enzyme-specific antibody.
Detemination of the inhzbitory effect of immune sera on hexokina8e activity. The methods used were (a) the measurement of the carbon dioxide evolved and (b) a direct titration of the hydrogen ions produced in the reaction. The results by both methods were analogous. The data reported here were obtained by the manometric measurement of carbon dioxide evolved. The method used was that of Colowick and Kalckar (1943) and Berger et al. (1946) In our experiments (figure 1) the main compartment of the Warburg flask contained 0.27 ml of 0.144 M sodium bicarbonate, 0.14 ml of 0.50 M glucose, 0.10 ml of hexokinase (1 mg protein per ml), 0.05 to 0.4 ml of serum, and 0.77 to 1.12 ml of 0.9 per cent sodium chloride, pH 7.5. The side arm contained 0.58 ml of 0.04 M ATP (sodium salt, pH 7.5), 0.07 ml of 0.2 M magnesium chloride, and 0.07 ml of 0.1 M sodium bicarbonate. The final volume of the system was 2.4 ml. The experiment, the results of which are presented in figure 2, was conducted in the following manner: Double-armed flasks were used. Side arm (1) contained the serum and saline, total volume, 0.7 ml. Side arm (2) contained 0.58 ml of ATP. The main compartment of the flask contained 0.07 ml of magnesium chloride, 0.32 ml of sodium bicarbonate, 0.14 ml of glucose, 0.1 ml of hexokinase, and 0.49 ml of saline; pH 7.5. The ATP was added from side arm (2) after equilibration of the temperature was reached. The contents of side arm (1), immune or normal serum, were added after the reaction had been in progress for 20 minutes. The flask used as a thermobarometer contained all reagents except hexokinase and serum.
EXPERIMENTAL RESULTS
The results presented here show that rabbit immune serum prepared against yeast hexokinase completely inhibits the latter's activity. The high specificity of this reaction is indicated by the fact that (a) a rabbit immune serum prepared against the same enzyme preparation suspended in Falba mineral oil, even though it produced an immune serum with higher precipitating and complementfixing titer, was incapable of exercising an inhibitory effect on the hexokinase
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R. E. MILLER, V. Z. PASTERNAK, AND M. G. SEVAG activity; (b) a rabbit immune serum prepared against streptococcal hyaluronidase4 likewise failed to inhibit hexokinase activity; and (c) an aqueous extract of rat brain (8 ml of chilled distilled water per rat brain) as the source of mammalian hexokinase, when substituted for yeast hexokinase, was not inhibited by rabbit normal and antiyeast hexokinase sera. Three-tenths ml of brain extract was approximately equivalent in activity to 0.1 ml of our yeast hexokinase preparation.
Four-tenths ml of immune serum completely inhibits the activity of 0.1 ml of hexokinase solution. The inhibitions by 0.05 ml, 0.1 ml, and 0.2 ml of immune serum are, respectively, 42, 73, and 94 per cent (figure 1). The data presented in figure 2 show a similar qualitative relationship with respect to the inhibition with various volumes of immune serum. The optimal volume (0.4 ml) of immune serum, added at a time when hexokinase activity was at its peak, brought about an immediate inhibitory effect, which persisted through the 2-hour period. This relationship between an enzyme and its homologous antibody would appear to be analogous to the inhibition of enzymes with specific inhibitors. A specific antiserum inhibitory for yeast D-glyceraldehyde-3-phosphate dehydrogenase has been described by Krebs and Najjar (1948) . For a discussion of immune reactions involving other enzymes see Sevag (in press ).
SUMMARY
Antiserum against yeast hexokinase has been produced in the rabbit. This serum, added to the reaction system at the beginning or after the reaction has progressed for 20 minutes, inhibits the activity of the enzyme. Under optimal conditions the inhibitory effect of the antiserum is immediate.
Yeast hexokinase antiserum had no effect on the activity of rat brain hexokinase, nor did a rabbit antihyaluronidase serum show an inhibitory effect on yeast hexokinase. These facts show a high degree of specificity of the inhibitory action of the antiserum obtained.
